Hybrid pipeline swells as Merck hits the road
Merck KGaA, the Darmstadt-based pharmaceutical company, has mandated banks for a hybrid bond issue, as part of the refinancing of loans for its $17bn (€13bn) acquisition of Sigma-Aldrich, the US life sciences and high tech materials group.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
